Related Experiment Video

Updated: May 16, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Candesartan plus hydrochlorothiazide: an overview of its use and efficacy

Amedeo Mugellini1, Valentina Nieswandt

  • 1University of Pavia, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, Fondazione IRCC Policlinico S. Matteo, Piazzale Golgi 19, 27100 Pavia, Italy. amedeo.mugellini@unipv.it

Expert Opinion on Pharmacotherapy
|November 23, 2012
PubMed

Insights

Fixed-dose candesartan cilexetil/hydrochlorothiazide effectively lowers blood pressure (BP) and prevents organ damage. This combination therapy offers good tolerability and patient compliance for hypertension management.

Area of Science:

  • Cardiology
  • Pharmacology
  • Nephrology

Background:

  • The 2007 European Society of Cardiology/European Society of Hypertension guidelines recommend angiotensin receptor blockers as a key component of antihypertensive combination therapy.
  • Thiazide-type diuretics are commonly added to enhance blood pressure (BP) lowering efficacy.
  • Fixed-dose combinations, such as candesartan cilexetil/hydrochlorothiazide, have demonstrated superior BP reduction compared to other agents in the same class.

Purpose of the Study:

  • To analyze the significance of combining candesartan cilexetil with hydrochlorothiazide for hypertension treatment.
  • To highlight the effectiveness of combination therapy in achieving optimal BP control, particularly in high-risk patients.

Main Methods:

  • Review and analysis of existing literature on candesartan cilexetil/hydrochlorothiazide combination therapy.
  • Evaluation of BP control achieved through combination therapy with drugs having different mechanisms of action.

Main Results:

  • Combination therapy is crucial for effective BP control, especially in patients with diabetes mellitus or chronic renal disease requiring intensive management.
  • Candesartan cilexetil/hydrochlorothiazide combination demonstrates high efficacy in reducing BP.
  • This combination exhibits good tolerability and patient compliance with minimal adverse reactions.

Conclusions:

  • Fixed-dose candesartan/hydrochlorothiazide is a valuable therapeutic option for hypertension.
  • Its efficacy in BP reduction and prevention of target organ damage, coupled with favorable tolerability and compliance, makes it a significant alternative.
  • Combination therapy is essential for achieving target BP levels in complex patient populations.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...